Clinical Trials
3 trialsNCT05116137 2026-05-29
RESIST
Nova Scotia Health Authority
Phase NA Enrolling by invitation
NCT06626919 2026-02-25
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Arcellx, Inc.
Phase 1 Recruiting
NCT01395563 2015-03-13
STOPC
German Cancer Research Center
Phase NA Withdrawn